Efficacy of a Unani formulation in Bronchial Asthma

Efficacy of a Unani formulation in Zeequn nafas shoabi (Bronchial Asthma)

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/07/015124

Enrollment

Registered

2018-07-30

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Diagnosed case of Bronchial Asthma Health Condition 2: J454- Moderate persistent asthma

Interventions

Intervention1: Decoction of Unani Formulation: In form of Decoction Twice in a day Control Intervention1: None: None

Eligibility

Inclusion criteria

Inclusion criteria: • Mild (PEF >= 70 %) and moderate asthma (PEF 40â??69 %) 12. • Patients belonging to 18-60 years of age of both genders.

Exclusion criteria

Exclusion criteria: • Severe asthma • Received sympathomimetic or anticholinergic bronchodilator with in 24 hrs prior to enrollment • Patients with known systemic and metabolic disorders • Pregnant and lactating women • A history of sensitivity to Î²-agonists

Design outcomes

Primary

Measure	Time frame
Improvement in ACT score Timepoint: Improvement in ACT score	—

Secondary

Measure	Time frame
Improvement in FEV1, FEV1/FVC ratio, PEF Timepoint: 30 Days	—

Countries

India

Contacts

Public ContactDr Muzafar Din Ahmad Bhat

NIUM

drmuzaffar79@gmail.com9590366192

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026